Skip to content
2000
Volume 30, Issue 4
  • ISSN: 1385-2728
  • E-ISSN: 1875-5348

Abstract

Dimroth rearrangement is a type of molecular rearrangement involving the interconversion of triazoles under acidic or basic conditions. It is particularly significant in heterocyclic chemistry, and it involves the migration of substituents around the nitrogen atoms in the ring system. This review concerns the formation of fused five-membered 1,2,4-triazolo[4,3-]pyrimidines from their corresponding 4-hydrazinopyrimidine derivatives. Additionally, it discusses their Dimroth-type rearrangement into the thermodynamically more stable 1,2,4-triazolo[1,]pyrimidine isomers under various reaction conditions. Moreover, it was observed that the presence of an acid, base, and aliphatic substituents in C3 and C5 of triazolo[4,3-]pyrimidine structure facilitates the Dimroth-type rearrangement. In general, the two isomeric series differ significantly in their melting points, proton NMR chemical shift positions, and UV absorption wavelengths.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/coc/10.2174/0113852728385677250513065230
2025-05-29
2026-03-01

  • From This Site

    /content/journals/coc/10.2174/0113852728385677250513065230
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. ShishooC.J. DevaniM.B. UllasG.V. AnanthanS. BhadtiV.S. Studies in the synthesis and interconversion of isomeric triazolothienopyrimidines.J. Heterocycl. Chem.1981181434610.1002/jhet.5570180109
     [Google Scholar]
  2. ShishooC.J. DevaniM.B. UllasG.V. AnanthanS. BhadtiV.S. Studies on the synthesis of 2‐(2‐arylvinyl)thieno[2,3‐d]pyrimidines and 5‐(2‐arylvinyl)triazolothieno[3,2‐e]pyrimidines.J. Heterocycl. Chem.198522382583010.1002/jhet.5570220343
     [Google Scholar]
  3. ShishooC.J. DevaniM.B. UllasG.V. AnanthanS. BhadtiV.S. Studies on the synthesis and interconversion of isomeric triazolotheinopyrimidines. Part II. Effect of 5-substituents on the dimroth rearrangement of 1,2,4-triazolo[4,3-c]thieno[3,2-e]pyrimidines.J. Heterocycl. Chem.19852283183310.1002/jhet.5570220344
     [Google Scholar]
  4. MohamedM.S. RashadA.E. ZakiM.E.A. FatahalaS.S. Synthesis and antimicrobial screening of some fused heterocyclic pyrroles.Acta Pharm.200555323724916375835
     [Google Scholar]
  5. RashadA.E. HeikalO.A. El-NezhawyA.O.H. Abdel-MegeidF.M.E. Synthesis and isomerization of thienotriazolopyrimidine and thienotetrazolopyrimidine derivatives with potential anti-inflammatory activity.Heteroatom Chem.20051622623410.1002/hc.20114
     [Google Scholar]
  6. ShamroukhA.H. ZakiM.E.A. MorsyE.M.H. Abdel-MottiF.M. Abdel-MegeidF.M.E. Synthesis, isomerization, and antimicrobial evaluation of some pyrazolopyranotriazolopyrimidine derivatives.Arch. Pharm. (Weinheim)2007340734535117610300
     [Google Scholar]
  7. RashadA. ShamroukhA. Abdel-MegeidR. AliH. Synthesis and isomerization of some novel pyrazolopyrimidine and pyrazolotriazolopyrimidine derivatives.Molecules20141955459546910.3390/molecules1905545924776812
     [Google Scholar]
  8. DimrothO. On intramolecular rearrangements. Rearrangements in the 1,2,3-triazole series.Justus Liebigs Ann. Chem.190936418310.1002/jlac.19093640204
     [Google Scholar]
  9. BrownD.J. HoergerE. MasonS.F. Simple pyrimidines. Part III. The methylation and structure of the aminopyrimidines.J. Chem. Soc.1955403510.1039/jr9550004035
     [Google Scholar]
  10. CarringtonH.C. CurdF.H.S. RichardsonD.N. The synthesis of trypanocides. Part V. A rearrangement of some 6-amino-1-methylpyrimidinium salts, and the synthesis of 4-amino-1 : 2-dimethyl-6-(1:2-dimethyl-6-methylaminopyrimidinium-4-amino)-quinolinium di-iodide.J. Chem. Soc.19551955185810.1039/jr9550001858
     [Google Scholar]
  11. BrownD.J. HarperJ.S. The Dimroth rearrangement. Part I. Some alkylated 2-iminopyrimidines.J. Chem. Soc.1963127610.1039/jr9630001276
     [Google Scholar]
  12. ShabanM.A.E. MorgaanA.E.A. The chemistry of 1,2,4-triazolopyrimidines II: l,2,4-triazolo[4,3-c]pyrimidines.Adv. Heterocycl. Chem.19997524328110.1016/S0065‑2725(08)60986‑1
     [Google Scholar]
  13. ShabanM.A.E. MorgaanA.E.A. Chemistry of 1,2,4-triazolopyrimidines III: 1,2,4-triazolo[1,5-c]pyrimidines.Adv. Heterocycl. Chem.20007734539410.1016/S0065‑2725(00)77009‑7
     [Google Scholar]
  14. KrajczykA. BoryskiJ. Dimroth rearrangement-old but not outdated.Curr. Org. Chem.201721252515252910.2174/1385272821666170427125720
     [Google Scholar]
  15. FerreiraV.F. SilvaT.B. PauliF.P. FerreiraP.G. ForeziL.S.M. LimaC.G.S. SilvaF.C. Dimroth’s rearrangement as a synthetic strategy towards new heterocyclic compounds.Curr. Org. Chem.20202411999201810.2174/1385272824999200805114837
     [Google Scholar]
  16. Sheikhi-MohammarehS. ShiriA. MagueJ. Dimroth rearrangement-based synthesis of novel derivatives of [1,3]selenazolo[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine as a new class of selenium-containing heterocyclic architecture.Mol. Divers.202226292393710.1007/s11030‑021‑10203‑933721152
     [Google Scholar]
  17. SirakanyanS.N. GeronikakiA. SpinelliD. HovakimyanA.A. NoravyanA.S. Synthesis and structure of condensed triazolo- and tetrazolopyrimidines.Tetrahedron20136949106371064310.1016/j.tet.2013.10.015
     [Google Scholar]
  18. WangM. ZhangG. WangY. WangJ. ZhuM. CenS. WangY. Design, synthesis and anti-influenza A virus activity of novel 2,4-disubstituted quinazoline derivatives.Bioorg. Med. Chem. Lett.2020301112714310.1016/j.bmcl.2020.12714332273213
     [Google Scholar]
  19. MamedovV.A. ZhukovaN.A. KadyrovaM.S. The Dimroth rearrangement in the synthesis of condensed pyrimidines - structural analogs of antiviral compounds.Chem. Heterocycl. Compd.202157434236810.1007/s10593‑021‑02913‑734024912
     [Google Scholar]
  20. LauriaA. PatellaC. AbbateI. MartoranaA. AlmericoA.M. An unexpected Dimroth rearrangement leading to annelated thieno[3,2-d][1,2,3]triazolo[1,5-a]pyrimidines with potent antitumor activity.Eur. J. Med. Chem.20136538138810.1016/j.ejmech.2013.05.01223747807
     [Google Scholar]
  21. SirakanyanS.N. SpinelliD. GeronikakiA. KartsevV.G. HakobyanE.K. HovakimyanA.A. Synthesis of new heterocyclic systems: Pyrido[3′,2′:4,5]thieno(furo)[2,3‐e][1,2,4]triazolopyrimidines and an unusual ANRORC rearrangement in the fused pyrimidine series.ChemistrySelect2018339109381094210.1002/slct.201802221
     [Google Scholar]
  22. KohandelO. Sheikhi-MohammarehS. OroojalianF. MemarianiT. MagueJ. ShiriA. A Dimroth rearrangement approach for the synthesis of selenopheno[2,3-e][1,2,4]triazolo[1,5-c]pyrimidines with cytotoxic activity on breast cancer cells.Mol. Divers.20222631621163310.1007/s11030‑021‑10290‑834357512
     [Google Scholar]
  23. RashadA.E. El MalahT. ShamroukhA.H. Developments of pyrrolo[2,3-d]pyrimidines with pharmaceutical potential.Curr. Org. Chem.202428161244126410.2174/0113852728306820240515054401
     [Google Scholar]
  24. MohamedA.M. El-SayedW.A. IbrahimA.A. Abdel-HafezN.A. AliK.A.K. MohamedS.F. Recent trends in the chemistry of [1,2,4]triazolo[1,5-a]pyrimidines.Org. Prep. Proced. Int.202153321123910.1080/00304948.2020.1871310
     [Google Scholar]
  25. ChampiréA. ValaC. LaabidA. BenharrefA. MarchivieM. PléK. RoutierS. Controlled dimroth rearrangement in the suzuki-miyaura cross coupling of triazolopyridopyrimidines.J. Org. Chem.20168124125061251310.1021/acs.joc.6b0235727978739
     [Google Scholar]
  26. SalemM.A. BehaloM.S. KhidreR.E. Recent trend in the chemistry of triazolopyrimidines and their applications.Mini Rev. Org. Chem.20211881134114910.2174/1570193X18666210203155358
     [Google Scholar]
  27. RashadA.E. ShamroukhA.H. HegabM.I. AwadH.M. Synthesis of some biologically active pyrazoles and C-nucleosides.Acta Chim. Slov.200552429434
     [Google Scholar]
  28. L’AbbéG. VanderstedeE. Dimroth rearrangement of 5‐hydrazino‐1,2,3‐thiadiazoles.J. Heterocycl. Chem.19892661811181410.1002/jhet.5570260652
     [Google Scholar]
  29. NagamatsuT. FujitaT. The first reliable, general synthesis of the 5-oxo derivatives of 5,6-dihydro-1,2,4-triazolo[4,3-c]pyrimidine and the rates of isomerization of the [4,3-c] compounds into their [1,5-c] isomers.Heterocycles200257463163610.3987/COM‑02‑9450
     [Google Scholar]
  30. LoakesD. BrownD.M. SalisburyS.A. Cyclisation and rearrangement of N4-acylaminodeoxycytidines.Tetrahedron Lett.199839223865386810.1016/S0040‑4039(98)00634‑0
     [Google Scholar]
  31. TyurinR.V. Vorob’evE.V. MinyaevaL.G. KrasnikovV.V. MezheritskiiV.V. Alternative Routes to the Pyrazolo[4,3-e][1,2,4]triazolo-[1,5-c]pyrimidine System.Russ. J. Org. Chem.200541691692110.1007/s11178‑005‑0266‑z
     [Google Scholar]
  32. FoucourtA. Dubouilh-BenardC. ChossonE. CorbièreC. BuquetC. IannelliM. LeblondB. MarsaisF. BessonT. Microwave-accelerated Dimroth rearrangement for the synthesis of 4-anilino-6-nitroquinazolines. Application to an efficient synthesis of a microtubule destabilizing agent.Tetrahedron201066254495450210.1016/j.tet.2010.04.066
     [Google Scholar]
  33. BabuD.D. Saranga PaniA. JoshiS.D. NaikP. JayaprakashG.K. Al-GhorbaniM. RodriguesB. MomidiB.K. Computational and experimental insights into pharmacological potential: Synthesis, in vitro evaluation, and molecular docking analysis of bioactive urea and thiourea derivatives.Microb. Pathog.202520010720910.1016/j.micpath.2024.10720939653284
     [Google Scholar]
  34. KumarB.M. HariprasadV. JoshiS.D. JayaprakashG.K. ParashuramL. PaniA.S. BabuD.D. NaikP. Bis(azolyl)pyridine‐2,6‐dicarboxamide derivatives: Synthesis, bioassay analysis and molecular docking studies.ChemistrySelect2023812e20220492710.1002/slct.202204927
     [Google Scholar]
  35. MallikarjunaswamyA.M.M. NaikP. KumarM.B. GouthamiK. ReddyV.D. NairV.A. Synthesis and antimicrobial evaluation of 2-thioxoimidazolidinone derivatives.Org. Commun.20241717819210.25135/acg.oc.174.21.3340
     [Google Scholar]
  36. KumarM.B. HariprasadV. JoshiS.D. NaikP. JayaprakashG.K. PaniA.S. BabuD.D. Exploring the antimicrobial potential of pyrimidine linked hydrazinyl azole derivatives: Insights from biological assays and molecular docking studies.ChemistrySelect2023844e20230199810.1002/slct.202301998
     [Google Scholar]
  37. SoniI. KumariA. JayaprakashG.K. NaikP. RajendrachariS. Evaluation of the role of ionic liquid as a modifier for carbon paste electrodes in the detection of anthracyclines and purine-pyrimidine-based anticancer agents.Mater. Res. Express202411101200510.1088/2053‑1591/ad1bff
     [Google Scholar]
  38. RashidH. MartinesM.A.U. DuarteA.P. JorgeJ. RasoolS. MuhammadR. AhmadN. UmarM.N. Research developments in the syntheses, anti-inflammatory activities and structure-activity relationships of pyrimidines.RSC Advances202111116060609810.1039/D0RA10657G35423143
     [Google Scholar]
  39. AlidmatM.M. KhairuddeanM. NormanN.M. AsriA.N.M. SuhaimiM.H.M. SharmaG. Synthesis, characterization, docking study and biological evaluation of new chalcone, pyrazoline, and pyrimidine derivatives as potent antimalarial compounds.Arab. J. Chem.20211410330410.1016/j.arabjc.2021.103304
     [Google Scholar]
  40. PeytamF. TakalloobanafshiG. SaadattalabT. NorouzbahariM. EmamgholipourZ. MoghimiS. FiroozpourL. BijanzadehH.R. FaramarziM.A. MojtabaviS. Rashidi-RanjbarP. KarimaS. PakraadR. ForoumadiA. Design, synthesis, molecular docking, and in vitro α-glucosidase inhibitory activities of novel 3-amino-2,4-diarylbenzo[4,5]imidazo[1,2-a]pyrimidines against yeast and rat α-glucosidase.Sci. Rep.20211111191110.1038/s41598‑021‑91473‑z34099819
     [Google Scholar]
  41. RomeoR. IannazzoD. VeltriL. GabrieleB. MacchiB. FrezzaC. Marino-MerloF. GiofrèS.V. Pyrimidine 2,4-diones in the design of new HIV RT inhibitors.Molecules2019249171831052607
     [Google Scholar]
  42. UgwuD.I. OkoroU.C. MishraN.K. Synthesis, characterization and anthelmintic activity evaluation of pyrimidine derivatives bearing carboxamide and sulphonamide moieties.J. Serb. Chem. Soc.20188340140910.2298/JSC170127109U
     [Google Scholar]
  43. KrólM. ŚlifirskiG. KlepsJ. UlenbergS. BelkaM. BączekT. SiwekA. StachowiczK. SzewczykB. NowakG. DuszyńskaB. HeroldF. Synthesis of novel pyrido[1,2-c]pyrimidine derivatives with 6-fluoro-3-(4-piperidynyl)-1,2-benzisoxazole moiety as potential SSRI and 5-HT1A receptor ligands.Int. J. Mol. Sci.2021225232910.3390/ijms2205232933652672
     [Google Scholar]
  44. BassyouniF. TarekM. SalamaA. IbrahimB. Salah El DineS. YassinN. HassaneinA. MoharamM. Abdel-RehimM. Promising antidiabetic and antimicrobial agents based on fused pyrimidine derivatives: Molecular modeling and biological evaluation with histopathological effect.Molecules2021268237010.3390/molecules2608237033921827
     [Google Scholar]
  45. AwadS.M. ZohnyY.M. AliS.A. MahgoubS. SaidA.M. Design, synthesis, molecular modeling, and biological evaluation of novel thiouracil derivatives as potential antithyroid agents.Molecules20182311291310.3390/molecules2311291330413058
     [Google Scholar]
  46. PengZ. WangG. ZengQ.H. LiY. WuY. LiuH. WangJ.J. ZhaoY. Synthesis, antioxidant and anti-tyrosinase activity of 1,2,4-triazole hydrazones as antibrowning agents.Food Chem.2021341Pt 212826510.1016/j.foodchem.2020.12826533031957
     [Google Scholar]
  47. StrzeleckaM. ŚwiątekP. 1,2,4-triazoles as important antibacterial agents.Pharmaceuticals202114322410.3390/ph1403022433799936
     [Google Scholar]
  48. AppnaN.R. NagiriR.K. KorupoluR.B. KanugalaS. ChityalG.K. ThipparapuG. BandaN. Design and synthesis of novel 4-hydrazone functionalized/1,2,4-triazole fused pyrido[2,3-d]pyrimidine derivatives, their evaluation for antifungal activity and docking studies.Med. Chem. Res.2019281509152810.1007/s00044‑019‑02390‑w
     [Google Scholar]
  49. El SawyM.A. ElshatanofyM.M. El KilanyY. KandeelK. ElwakilB.H. HagarM. AouadM.R. AlbelwiF.F. RezkiN. JaremkoM. El AshryE.S.H. Novel hybrid 1,2,4- and 1,2,3-triazoles targeting Mycobacterium Tuberculosis enoyl acyl carrier protein reductase (InhA): Design, synthesis, and molecular docking.Int. J. Mol. Sci.2022239470635563096
     [Google Scholar]
  50. GrytsaiO. ValiashkoO. Penco-CampilloM. DufiesM. HagegeA. DemangeL. MartialS. PagèsG. RoncoC. BenhidaR. Synthesis and biological evaluation of 3-amino-1,2,4-triazole derivatives as potential anticancer compounds.Bioorg. Chem.202010410427110.1016/j.bioorg.2020.10427132992279
     [Google Scholar]
  51. KhanB. NaiyerA. AtharF. AliS. ThakurS.C. Synthesis, characterization and anti-inflammatory activity evaluation of 1,2,4-triazole and its derivatives as a potential scaffold for the synthesis of drugs against prostaglandin-endoperoxide synthase.J. Biomol. Struct. Dyn.202139245747510.1080/07391102.2019.171119331900051
     [Google Scholar]
  52. KaprońB. ŁuszczkiJ.J. SiwekA. KarczT. NowakG. ZagajaM. Andres-MachM. StasiłowiczA. Cielecka-PiontekJ. KockiJ. PlechT. Preclinical evaluation of 1,2,4-triazole-based compounds targeting voltage-gated sodium channels (VGSCs) as promising anticonvulsant drug candidates.Bioorg. Chem.20209410335510.1016/j.bioorg.2019.10335531662213
     [Google Scholar]
  53. Ben HassenM. MsalbiD. JismyB. ElghaliF. AifaS. AllouchiH. AbarbriM. ChabchoubF. Three component one-pot synthesis and antiproliferative activity of new [1,2,4]triazolo[4,3-a]pyrimidines.Molecules2023289391710.3390/molecules2809391737175327
     [Google Scholar]
  54. HassanM. BarsyM.A. El RadyE.A. Al-AyedA.S. FrempongM. SadekK.U. Application of the aza‐wittig reaction for efficient synthesis of diversely substituted benzo[f]Chromeno[2,3‐d]pyrimidine and benzo[f]chromeno[2,3‐d][1,2,4]triazolopyrimidine derivatives.J. Heterocycl. Chem.202461454354910.1002/jhet.4784
     [Google Scholar]
  55. MohamedH.S. AminN.H. El-SaadiM.T. Abdel-RahmanH.M. Design, synthesis, biological assessment, and in-Silico studies of 1,2,4-triazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors.Bioorg. Chem.202212110568710.1016/j.bioorg.2022.10568735196595
     [Google Scholar]
  56. NgJ.H. DolzhenkoA.V. One-pot synthesis of novel pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines under microwave irradiation in a green solvent.Tetrahedron202314113352113352910.1016/j.tet.2023.133521
     [Google Scholar]
  57. LiZ. YuanY. WangP. ZhangZ. MaH. SunY. ZhangX. LiX. QiaoY. ZhangF. SuY. SongJ. XieZ. LiL. MaL. MaJ. ZhangZ. Design, synthesis and in vitro, in vivo anticancer activity of tranylcypromine-based triazolopyrimidine analogs as novel LSD1 inhibitors.Eur. J. Med. Chem.202325311532110.1016/j.ejmech.2023.11532137037137
     [Google Scholar]
  58. FeitosaL.M. FrancaR.R.F. FerreiraM.L.G. AguiarA.C.C. de SouzaG.E. MalufS.E.C. de SouzaJ.O. ZapataL. DuarteD. MoraisI. NogueiraF. NonatoM.C. PinheiroL.C.S. GuidoR.V.C. BoechatN. BoechatN. Discovery of new piperaquine hybrid analogs linked by triazolopyrimidine and pyrazolopyrimidine scaffolds with antiplasmodial and transmission blocking activities.Eur. J. Med. Chem.202426711616310.1016/j.ejmech.2024.11616338290351
     [Google Scholar]
  59. LuoJ. NieH. HeL. ZhaoA. WangT. New library of pyrimido[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives: Synthesis, herbicidal activity, and molecular docking study.J. Mol. Struct.2024130013724610.1016/j.molstruc.2023.137246
     [Google Scholar]
  60. KandeelM.M. RefaatH.M. KassabA.E. ShahinI.G. AbdelghanyT.M. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.Eur. J. Med. Chem.20159062063210.1016/j.ejmech.2014.12.00925499930
     [Google Scholar]
  61. RagabS.S. IbrahimN.E. Abdel-AzizM.S. ElrashedyA.A. AllayehA.K. Synthesis, biological activity, and molecular dynamic studies of new triazolopyrimidine derivatives.Results Chem.2023610116310.1016/j.rechem.2023.101163
     [Google Scholar]
  62. NazariS. ZabihzadehM. ShiriniF. TajikH. A dicationic molten salt catalyzed synthesis of 1,2,4-Triazolopyrimidine, Quinazolinone and Biscoumarin derivatives under green conditions.Polycycl. Aromat. Compd.20234321524153510.1080/10406638.2022.2030765
     [Google Scholar]
  63. NieH. HeL. ZhaoA. HuangH. WangT. LuoJ. Design, synthesis, and biological activity of new 8-decylthio-10-methylthio-pyrimido[5,4- e][1,2,4]triazolo[1,5-c]pyrimidine derivatives.Phosphorus Sulfur Silicon Relat. Elem.20241991374410.1080/10426507.2023.2245528
     [Google Scholar]
  64. SinghS. LakhiaR. YadavS. DeviP. YadavK. ChaudhriV. PundeerR. Advancements in the synthesis of Triazolopyrimidines.Curr. Org. Chem.202428201567157810.2174/0113852728313437240607095009
     [Google Scholar]
  65. ShamroukhA.H. MalahT.E. RashadA.E. The Chemistry and Biological Effects of Fused 1,2,4-triazolo[4,3-c]pyrimidines and their Isomeric 1,2,4-triazolo[1,5-c]pyrimidines.Curr. Org. Chem.202529425927310.2174/0113852728331504240820050800
     [Google Scholar]
  66. El MrayejH. En-nabetyG. EttahiriW. JghaouiM. SabbahiR. HammoutiB. RaisZ. TalebM. Triazolopyrimidine derivatives: A comprehensive review of their synthesis, reactivity, biological properties, and molecular docking studies.Indones J. Sci. Technol.2025104174
     [Google Scholar]
  67. RomagnoliR. De VenturaT. ManfrediniS. BaldiniE. SupuranC.T. NocentiniA. BrancaleA. VarricchioC. BortolozziR. ManfredaL. ViolaG. Design, synthesis, and biological investigation of selective human carbonic anhydrase II, IX, and XII inhibitors using 7-aryl/heteroaryl triazolopyrimidines bearing a sulfanilamide scaffold.J. Enzyme Inhib. Med. Chem.2023381227018010.1080/14756366.2023.227018037850364
     [Google Scholar]
  68. MillerG.W. RoseF.L. S-triazolopyrimidines. Part I. Synthesis as potential therapeutic agents.J. Chem. Soc.19645642564410.1039/JR9630005642
     [Google Scholar]
  69. MillerG.W. RoseF.L. s-Triazolopyrimidines. Part II. Synthesis as potential therapeutic agents.J. Chem. Soc.19653357336810.1039/jr965000335714298466
     [Google Scholar]
  70. Hassan HilmyK.M. KhalifaM.M.A. Allah HawataM.A. AboAlzeen KeshkR.M. El-TorgmanA.A. Synthesis of new pyrrolo[2,3-d]pyrimidine derivatives as antibacterial and antifungal agents.Eur. J. Med. Chem.201045115243525010.1016/j.ejmech.2010.08.04320828885
     [Google Scholar]
  71. MohamedM.S. KamelR. FatahalaS.S. New condensed pyrroles of potential biological interest.Eur. J. Med. Chem.20114673022302910.1016/j.ejmech.2011.04.03421549457
     [Google Scholar]
  72. NagamatsuT. AhmedS. HossionA-G.M.L. OhnoS. Synthesis of Thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-5(6H)-ones via their [1,2,4] triazolo[4,3-c]pyrimidine compounds as new ring systems by dimroth-type rearrangement.Heterocycles20077377779310.3987/COM‑07‑S(U)58
     [Google Scholar]
  73. VlasovS.V. Synthesis and antimicrobial activity of 3-(thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-2-yl)propanoic and butanoic acids.Pharma Chem.20157112631
     [Google Scholar]
  74. Abdel-FattahB. KandeelM.M. Abdel-HakeemM. FahmyZ.M. Synthesis of certain fused thienopyrimidines of biological interest.J. Chin. Chem. Soc. (Taipei)200653240341210.1002/jccs.200600051
     [Google Scholar]
  75. HegabM.I. HassanN.A. RashadA.E. FahmyA.A. Abdel-MegeidF.M.E. Synthesis, reactions, and antimicrobial activity of some fused thieno[2,3- d]pyrimidine derivatives.Phosphorus Sulfur Silicon Relat. Elem.200718271535155610.1080/10426500701247151
     [Google Scholar]
  76. GuetzoyanL.J. SpoonerR.A. LordJ.M. RobertsL.M. ClarksonG.J. Simple oxidation of pyrimidinylhydrazones to triazolopyrimidines and their inhibition of Shiga toxin trafficking.Eur. J. Med. Chem.201045127528310.1016/j.ejmech.2009.10.00719883956
     [Google Scholar]
  77. MarzoukN.A. ShamroukhA.H. Al-SaadnyA.H. MickyJ.A. Synthesis, isomerization, and antimicrobial evaluation of some indenothienopyrimidine derivatives.Am. J. Sci.20117836236910.13140/RG.2.2.10388.42884
     [Google Scholar]
  78. RashadA.E. ShamroukhA.H. Abdel-MegeidR.E. SayedH.H. Abdel-WahedN.A. Studies on the reactivity of (9-Methyl-5,6-dihydronaphtho [1′,2′:4,5]thieno[2,3-d]pyrimidin-11-yl)hydrazine towards some reagents for biological evaluation.Sci. Pharm.201078111210.3797/scipharm.0910‑1121179366
     [Google Scholar]
  79. KumarV. KumarM. KumarS. (Diacetoxyiodo)Benzene mediated fused 1,2,4-triazole derivatives: Synthetic and medicinal perspective.Mini Rev. Org. Chem.2018161122510.2174/1570193X15666180406142116
     [Google Scholar]
  80. TangC. WangC. LiZ. WangQ. Synthesis of 8-Bromo-7-chloro[1, 2, 4] triazolo[4, 3-c]pyrimidines, their ring rearrangement to [1,5-c] analogues, and further diversification.Synthesis2014462734274610.1055/s‑0034‑1378453
     [Google Scholar]
  81. SirakanyanS.N. SpinelliD. GeronikakiA. KartsevV.G. HakobyanE.K. StepanyanH.M. ZuppiroliL. HovakimyanA.A. New cyclopenta[4′,5′]pyrido[3′,2′:4,5]thieno[2,3-e][1,2,4]triazolo[4,3-c]pyrimidines and cyclopenta[4′,5′]pyrido[3′,2′:4,5]thieno[2,3-e][1,2,4] triazolo[1,5-c]pyrimi-dines: Synthesis and antimicrobial activities.Curr. Org. Chem.201721131227124110.2174/1385272821666170222102400
     [Google Scholar]
  82. SirakanyanS.N. KartsevV.G. HovakimyanA.A. NoravyanA.S. ShakhatuniA.A. New Heterocyclic systems based on 5,6,7,8-tetrahydroisoquinolines.Chem. Heterocycl. Compd.2013481676168310.1007/s10593‑013‑1192‑6
     [Google Scholar]
  83. Abdel-MegeidF.M.E. HassanN.A. ZahranM.A. RashadA.E. Synthesis of 5,6-dihydronaphtho[1′,2′:4,5]thieno[2,3-d]pyrimidines, 5,6-dihydrona-phtho[1′,2′: 4,5]thieno[3,2-e] [1,2,4]triazolo[1,5-c]pyrimidines, and some of their nucleosides.Sulfur Lett.199821269284
     [Google Scholar]
  84. ParonikyanE.G. DashyanS.S. Synthesis of Cyclopenta[4′,5′]pyrido [3′,2′:4,5]thieno[3,2-d]pyrimidine derivatives. Dimroth rearrangement of triazolopyrimidines.Russ. J. Gen. Chem.2018881623162810.1134/S1070363218080121
     [Google Scholar]
  85. SirakanyanS.N. HakobyanE.K. HovakimyanA.A. Synthesis of new sulfur-substituted pentacyclic 1,2,4-Triazolopyrimidine derivatives.Russ. J. Org. Chem.201955330831310.1134/S1070428019030059
     [Google Scholar]
  86. OganisyanA.S. NoravyanA.S. KarapetyanA.A. AleksanyanM.S. StruchkovY.T. Derivatives of condensed Thienopyrimidimines. 13. Synthesis and structure of Pyrano[4′,3′:4,5]thieno[3,2-e]-[1,2,4]-triazolo[2,3-c]pyrimidines.Chem. Heterocycl. Compd.200137562863210.1023/A:1011668908331
     [Google Scholar]
  87. TangC. LiZ. WangQ. IBD-mediated oxidative cyclization of pyrimidinylhydrazones and concurrent Dimroth rearrangement: Synthesis of [1,2,4]triazolo[1,5-c]pyrimidine derivatives.Beilstein J. Org. Chem.201392629263410.3762/bjoc.9.29824367427
     [Google Scholar]
  88. VilaparaK. ButaniH. GamiS. KhuntH. NaliaparaY. One-pot sequential approach for the construction of highly functionalized Triazolo[4,3-c]pyrimidine library.Synth. Commun.201545202355236310.1080/00397911.2015.1083579
     [Google Scholar]
  89. KamalR. KumarV. KumarR. BhardwajJ.K. SarafP. KumariP. BhardwajV. Design, synthesis, and screening of Triazolopyrimidine-Pyrazole hybrids as potent apoptotic inducers.Arch. Pharm. (Weinheim)2017350111700137170014610.1002/ardp.20170013729034498
     [Google Scholar]
  90. HibotA. OumessaoudA. HafidA. KhouiliM. PujolM.D. Different synthetic methods for the preparation of Triazolopyrimidines and their biological profile.ChemistrySelect2023823e20230165410.1002/slct.202301654
     [Google Scholar]
  91. SonH.Y. SongY.H. A convenient synthesis of new 3,7-Diphenylthieno[3,2-e]bis[1,2,4] triazolo[4,3-a:4′,3′-c]pyrimidine derivatives by oxidative cyclization using alumina-supported calcium hypochlorite.Bull. Korean Chem. Soc.20103182242224610.5012/bkcs.2010.31.8.2242
     [Google Scholar]
  92. ShawaliA.S. HassaneenH.M. ShurrabN.K. A convenient synthesis of novel series of 4-cyclohexyl-2-substituted[1,2,4]triazolo[1,5-a]quinazolin-5(4H)-ones. Novel isoomers of H1 antihistaminic acitve agents.Heterocycles2008751479148810.3987/COM‑07‑11311
     [Google Scholar]
  93. El-GazzarA.B.A. HassanN.A. Synthesis of polynuclear heterocyclic compounds derived from thieno[2,3-d]pyrimidine derivatives.Molecules20005683585010.3390/50600835
     [Google Scholar]
  94. CiesielskiM. PufkyD. DöringM. A convenient new synthesis of fused 1,2,4-triazoles: The oxidation of heterocyclic hydrazones using copper dichloride.Tetrahedron200561245942594710.1016/j.tet.2005.01.111
     [Google Scholar]
  95. PrakashO. KumarR. KumarR. TyagiP. KuhadR.C. Organoiodine(III) mediated synthesis of 3,9-diaryl- and 3,9-difuryl-bis-1,2,4-triazolo[4,3-a][4,3-c]pyrimidines as antibacterial agents.Eur. J. Med. Chem.200742686887210.1016/j.ejmech.2006.11.01917222483
     [Google Scholar]
  96. HamedA.A. ZeidI.F. El-GanzoryH.H. Abdel AalM.T. Synthesis and structure of some thienopyrimidine derivatives.Monatsh. Chem.2008139780982010.1007/s00706‑007‑0823‑y
     [Google Scholar]
  97. KumarR. NairR.R. DhimanS.S. SharmaJ. PrakashO. Organoiodine (III)-mediated synthesis of 3-aryl/heteroaryl-5,7-dimethyl-1,2,4-triazolo[4,3-c]pyrimidines as antibacterial agents.Eur. J. Med. Chem.20094452260226410.1016/j.ejmech.2008.06.00418657340
     [Google Scholar]
  98. SongY.H. SonH.Y. Synthesis of new 1‐phenylthieno[1,2,4]triazolo[4,3‐ a]pyrimidin‐5(4H)‐one derivatives.J. Heterocycl. Chem.201148359760310.1002/jhet.549
     [Google Scholar]
  99. SonH.Y. SongY.H. A convenient synthesis of new 2-Phenylthieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives by dimroth rearrangement. J.Korean Chemical Society201054335035310.5012/jkcs.2010.54.3.350
     [Google Scholar]
  100. ShawaliA.S. HassaneenH.M. ShurrabN.K. A new strategy for the synthesis of pyrazolo[4,3-e][1,2,4]triazolo[4,3-c]pyrimidines and pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines.Tetrahedron20086445103391034310.1016/j.tet.2008.08.082
     [Google Scholar]
  101. ShurrabN.K. El-LouhA.K. Al-MeghariI.M. FerrwanahA.E.R. Synthesis of a new series of biphenyl-substituted, fused 1,2,4-triazoles by oxidative cyclisation and Dimroth rearrangement.J. Chem. Res.2013372919410.3184/174751913X13570601346457
     [Google Scholar]
/content/journals/coc/10.2174/0113852728385677250513065230
Loading
A Review of the Dimroth Rearrangement in Fused 1,2,4-Triazolo[4,3-c]pyrimidines
Current Organic Chemistry 30, 233 (2026); https://doi.org/10.2174/0113852728385677250513065230
/content/journals/coc/10.2174/0113852728385677250513065230
/content/journals/coc/10.2174/0113852728385677250513065230
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): 1,2,4-Triazolo[1,5-c]pyrimidines; 4-Hydrazinopyrimidines; aliphatic substituents; Dimroth; fused five-member 1,2,4-triazolo[4,3-c]pyrimidine; melting points; rearrangement

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test